Laura Sepp-Lorenzino, EVP, Chief Scientific Officer at Intellia Therapeutics, Inc. (NTLA), sold 1,148 shares at $112.25 ($129K) on 2022-01-01, disclosed to the SEC on 2022-03-03.
Open-market sale of $129k NTLA by EVP, Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| NTLA | SELL | 2024-01-05 | $326K | — | Filing → |
| NTLA | SELL | 2023-01-06 | $339K | — | Filing → |
| NTLA | SELL | 2021-09-01 | $30.0M | — | Filing → |